News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
831,665 Results
Type
Article (85613)
Company Profile (744)
Press Release (745308)
Section
Business (232258)
Career Advice (4105)
Deals (39644)
Drug Delivery (116)
Drug Development (90657)
Employer Resources (194)
FDA (17976)
Job Trends (17273)
News (395588)
Policy (39620)
Tag
Academia (2975)
Alliances (56460)
Alzheimer's disease (1336)
Approvals (17883)
Artificial intelligence (156)
Bankruptcy (394)
Best Places to Work (12521)
Biotechnology (509)
Breast cancer (131)
Cancer (1175)
Cardiovascular disease (109)
Career advice (3513)
Cell therapy (269)
Clinical research (71535)
Collaboration (418)
Compensation (204)
COVID-19 (2803)
C-suite (106)
Data (1151)
Diabetes (168)
Diagnostics (6681)
Earnings (94752)
Employer resources (167)
Events (126794)
Executive appointments (326)
FDA (18539)
Funding (375)
Gene therapy (202)
GLP-1 (695)
Government (5047)
Healthcare (20716)
Infectious disease (2897)
Inflammatory bowel disease (121)
Interviews (807)
IPO (17592)
Job creations (5178)
Job search strategy (2855)
Layoffs (489)
Legal (10044)
Lung cancer (190)
Manufacturing (202)
Medical device (14414)
Medtech (14419)
Mergers & acquisitions (22099)
Metabolic disorders (472)
Neuroscience (1643)
NextGen Class of 2024 (7657)
Non-profit (5064)
Northern California (1517)
Obesity (270)
Opinion (244)
Patents (111)
People (64179)
Pharmaceutical (147)
Phase I (22014)
Phase II (31068)
Phase III (23419)
Pipeline (466)
Postmarket research (3539)
Preclinical (9955)
Radiopharmaceuticals (258)
Rare diseases (244)
Real estate (7373)
Regulatory (25958)
Research institute (2641)
Resumes & cover letters (648)
Southern California (1343)
Startups (4276)
United States (14593)
Vaccines (652)
Weight loss (220)
Date
Today (155)
Last 7 days (911)
Last 30 days (4089)
Last 365 days (38517)
2024 (35333)
2023 (42566)
2022 (53928)
2021 (58726)
2020 (57671)
2019 (51341)
2018 (39125)
2017 (37191)
2016 (38330)
2015 (44433)
2014 (39673)
2013 (36268)
2012 (38416)
2011 (38383)
2010 (39616)
Location
Africa (1265)
Arizona (228)
Asia (49343)
Australia (8695)
California (3527)
Canada (1306)
China (262)
Colorado (155)
Connecticut (172)
Europe (113023)
Florida (473)
Georgia (127)
Illinois (417)
Indiana (216)
Kansas (103)
Maryland (631)
Massachusetts (2855)
Michigan (178)
Minnesota (298)
New Jersey (1003)
New York (998)
North Carolina (842)
Northern California (1517)
Ohio (148)
Pennsylvania (868)
South America (1647)
Southern California (1343)
Texas (507)
Washington State (399)
There are 831,665 results that match your search.
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Humacyte Clinical Results Highlighting Benefit of the ATEV™ in the Repair of Civilian and Military Arterial Injuries Published in JAMA Surgery
November 21, 2024
·
9 min read
Mergers & acquisitions
Novartis Buys Kate Therapeutics, Eyeing $55B CGT Market Opportunity by 2030
Novartis’ up to $1.1 billion acquisition of gene therapy specialist Kate Therapeutics fits with the pharma’s plan to expand its new modality pipeline to ensure long-term business sustainability.
November 21, 2024
·
2 min read
·
Tristan Manalac
Press Releases
Science 37 Nearly Doubles U.S. Enrollment for GSK Phase 3 Rare Disease Trial
November 21, 2024
·
3 min read
Press Releases
GRI Bio Showcases GRI-0621’s Potential to Reduce Inflammation, Type 1 Cytokines and Reduce Hepatic Fibrosis in Idiopathic Pulmonary Fibrosis (IPF)
November 21, 2024
·
8 min read
Press Releases
Cidara Therapeutics Announces $105 Million Private Placement
November 21, 2024
·
5 min read
Press Releases
Dyadic Receives $3 Million Grant to Develop Cost-Effective Monoclonal Antibodies for RSV and Malaria Using C1 Platform Technology
November 21, 2024
·
4 min read
Press Releases
neurocare Group AG Welcomes Kevin Reeder as Chief Financial Officer
November 21, 2024
·
2 min read
FDA Tracker
Jazz, Zymeworks Challenge Enhertu with FDA Win for Bispecific Antibody
In 2023, the FDA greenlit 55 new drugs and 34 cell and gene therapies. Follow along as
BioSpace
keeps you up to date on all of the FDA’s decisions in 2024.
November 21, 2024
·
204 min read
·
Heather McKenzie
Press Releases
Biofidelity launches Aspyre® Clinical Test for Lung, now providing next day results from tissue or blood
November 21, 2024
·
3 min read
Press Releases
Intelligent Bio Solutions to Participate in the Noble Capital Markets’ 20th Annual Emerging Growth Equity Conference
November 21, 2024
·
1 min read
1 of 83,167
Next
